Amgen, Inc. news

   Watch this stock
Showing stories 11 - 20 of about 146   

Articles published

AMGN 166.56 +0.89 (0.54%)
price chart
Active Biotech Stock News: Amgen Inc. (AMGN), Immunomedics Inc. (IMMU)
Amgen Inc. (AMGN) ended last trading session with a change of -0.27 percent. It trades at an average volume of 2.81M shares versus 2.25M shares recorded at the end of last trading session.
HC Stocks Highlights: Amgen, Inc. (NASDAQ:AMGN), Community Health Systems ...  share market updates (press release)
2 Biotech Stocks News And Price Trends: Amgen Inc. (NASDAQ:AMGN), ImmunoGen ...  The Voice Registrar
Price Target Update: Amgen Inc. (NASDAQ:AMGN)
The Company gained 0.45% and finished at $163.98. The daily volume was measured at 1.54 million shares. The 52-week high of the share price is $181.81 and the 52-week low is $130.09.
Biotech Companies To Look Out For: Exelixis, Inc. (EXEL), Amgen Inc. (AMGN)
Exelixis, Inc. (EXEL) ended last trading session with a change of 0.7 percent. It trades at an average volume of 6.2M shares versus 3.45M shares recorded at the end of last trading session.
HC Stocks News Ring: Amgen, Inc. (NASDAQ:AMGN), Novo Nordisk A/S (ADR) (NYSE ...  share market updates (press release)
Amgen submits BLA in US for osteoporosis candidate romosozumab  Seeking Alpha
Amgen, Inc. Receives Approval For Repatha Pushtronex
Amgen, Inc. (NASDAQ:AMGN) has announced the introduction of Repatha (evolocumab) Pushtronex system (on-body infusor with prefilled cartridge) by the Food and Drug Administration (FDA).
Amgen Gets FDA Approval For PCSK9 Inhibitor  Benzinga
FDA OKs once-per-month dosing of Amgen's Repatha  Seeking Alpha
Amgen Inc Realized Volatility Hits Extremely Low Level
This is a proprietary realized volatility rating created by Capital Market Laboratories (CMLviz) based on a large number of data interactions for Amgen Inc (NASDAQ:AMGN) . We examine the little used gem of daily stock volatilty over a 20-day and 30-day ...
Carter Worth And Mike Khouw's Amgen Trade
On CNBC's Options Action, Carter Worth analyzed Amgen, Inc. (NASDAQ: AMGN) from a technical standpoint. He said that the stock consistently outperformed iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB), which is in his opinion a basis for a ...
Global 20s Proteasome Pipeline Report 2016 – Therapeutics Activities of Amgen ...
logo187 The 20s Proteasome BTK Inc. - Product Pipeline Review - 2016 report offers a complete overview of the pharmaceutical research and development of the pipeline products that are developed by 20s Proteasome Inc. The report gives a ...
Hot Biotech Stocks Recap: Exelixis, Inc. (NASDAQ:EXEL), Amgen Inc. (NASDAQ:AMGN)
Exelixis, Inc. (NASDAQ:EXEL) climbed 1.91% by the end of recent close at $8.53. For the ongoing quarter, the 5 Wall Street analysts providing adjusted earnings per share outlook have a consensus estimate of -$0.27/share, which would compare with -$0.22 ...
Notable Analysts Recommendation to Monitor: Heat Biologics, Inc. (NASDAQ ...  Street Updates
HC Stocks Highlights: Amgen, Inc. (NASDAQ:AMGN), Sanofi SA (ADR) (NYSE:SNY)  share market updates (press release)
Amgen, Inc., Daiichi Sankyo to Launch 9 Biosimilars in Japan
Amgen, Inc. (NASDAQ:AMGN) has finalized an agreement with Daiichi Sankyo for the research and development of nine biosimilar versions of the blockbuster drugs.
Biotech Stocks Worth Chasing: Medivation, Inc. (MDVN), Amgen Inc. (AMGN)  Zergwatch
HC Stocks Momentum: Amgen, Inc. (NASDAQ:AMGN), Sanofi SA (ADR) (NYSE:SNY)  share market updates (press release)
Amgen Inc. (NASDAQ:AMGN) and UCB submit Biologics License Application to the ...
Amgen Inc. (NASDAQ:AMGN) traded 2.48 Million shares on last trading day with closing price of $165.67. Company gross margin stands at 81.00% whereas its return on investment (ROI) is 12.50%.
Valeant Pharmaceuticals Intl Inc: New Drug Prospects are at Risk  Bidness ETC